The effects of the opiate receptor agonists, enkephalins and morphine, and the antagonist, naloxone, on cerebrovascular resistance vessels was investigated in situ by employing perivascular microapplication. Feline pial arteries with a resting diameter of 66-294 f,Lm were tested. Vascular diameter was measured using television image splitting. Concentration-response curves revealed no change of diameter when Leu-enkephalin, o-Ala2-Leu enkephalinamide, o-Ala2-Met-enkephalinamide, and mor phine were applied in concentrations of 10-11_10-5 M.
(4.3%) elicited by D-Ala2-Leu-enkephalinamide was sta tistically significant (p < 0.01). All four agonists at 10-3 M induced significant dilatations varying between 5,4 and 13.6%. Naloxone exerted no vascular effect per se at 10-5 and 10-4 M but a dilatation of 15.3% at 10-3 M. The latter can be explained by a partial agonist action. During si multaneous administration, naloxone (10-4 M) reduced the dilatations induced by 10-4 and 10-3 M o-Ala2-Leu enkephalinamide dose dependently. This indicates that f,L and o-opioid receptors, probably located at the vascular smooth muscle cell, were involved in the mediation of the dilatation induced by the highest concentrations of the compounds. Key Words: Cat-Cerebrovascular smooth muscle-Microapplication-Opioid-like sub stances.
receptors has been found in microvessels using ra dioactive ligands (Peroutka et aI. , 1980) . The main functions of enkephalins appear to be their involvement in sensory transmission, anal gesia, and behavior. However, they have also been found to affect smooth muscle cells from several parts of the body by various mechanisms. The pre dominant action of enkephalins and synthetic ago nists is obviously the modulation of transmitter release from nerve endings, which is mediated by prejunctional receptors. Thus, they reduce the nerve-induced contraction of visceral and vascu lar smooth muscle, such as ileum, vas deferens (Wiister et aI. , 1979) , and ear artery (Knoll, 1976) .
A possible direct effect of enkephalins on receptors of vascular smooth muscle cells has been sug gested. Hanko and Hardebo (1978) found that iso lated feline middle cerebral arteries precontracted with prostaglandin F 2 a relaxed dose dependently during application of enkephalins or morphine. This effect was naloxone sensitive. Corresponding re sults were obtained in situ for arteries for the ham ster cheek pouch by Wong et al. (1981) . However, the opposite effect, contraction, has been reported for the isolated rat portal vein (Yamamoto et a!. , 1984) , suggesting important species differences.
Methionine-enkephalin (Sandor et aI. , 1983) and synthetic opiates such as morphine (Takeshita et aI. , 1972) and fentanyl (Safo et a!. , 1983) have been found to reduce CBF and CMR0 2 or tissue Po 2 . If in spontaneously breathing animals an increase of arterial Peo 2 was caused by morphine, a corre sponding increase of CBF was found. This increase in flow was even more than expected from the rise in arterial Peo 2 in the hippocampal region, caudate nucleus, and collicles (Koskinen and Bill, 1983) .
The latter might have been induced by an increased neuronal activity that was found especially at high concentrations of opioid receptor agonists (Safo et a!. , 1983; Ukponmwan et aI. , 1983) and may also depend on regionally varying sensitivity and distri bution of receptors. This is supported by the finding of a variable change of glucose uptake in different brain areas after administration of opioid agonists (Sakurada et aI. , 1978; Wiister et aI. , 1981) .
Thus, it appears most probable that the changes of CBF occurring during application of opioid com pounds are mainly secondary to alterations of neu ronal discharge and metabolism provided that ar terial Peo 2 and P0 2 remain constant. Therefore, it was the aim of the study to investigate whether opioid receptor agonists exert an additional, direct effect on pial arteries in situ.
METHODS
Experiments were performed on 19 cats of both sexes (2.0-4.6 kg body weight) anesthetized with a-chloralose (40-50 mg/kg i.v.) and immobilized with gallamine (15-20 mg/kg . h i. v.). The artificial ventilation of the cats using a Bird Mark 8 respirator was adjusted to obtain a stable continuously recorded end-tidal CO, of 4.3 1 ± 0. 18 vol% (mean ± SD). Arterial pH, Peo,: and Po, were measured intermittently at 38°C with Radiometer -equip ment. The following values were obtained: pH, 7.34 ± 0.035; Peo2, 29.6 ± 3.2 mm Hg; and Po" 126 ± 11 mm Hg. The value of the arterial Peo, was close to that mea sured in conscious cats by Herbert and Mitchell (197 1) . Body temperature was maintained at 37-38°C. Mean ar terial blood pressure continuously measured in a femoral artery varied between the individual experiments from 110 to 150 mm Hg with a mean value of 129 ± II mm Hg. Tyrode's solution (1.7 mIlkg . h) was infused intra venously to compensate fluid loss during the experi ments. A craniectomy in the left parietal region was per formed under a microscope using a cooled dental drill. After covering the dura and brain with a 1-2-cm-thick layer of warmed (37 -38°C) paraffin oil, the dura was slit. The diameter of extraparenchymal cerebral arteries and arterioles was measured with an image-splitting method using a Bausch and Lomb stereo-zoom microscope, a 625-line Grundig television camera, and a Watanabe mul- 
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The following compounds of analytical grade were tested: morphine (Merck), Leu-enkephalin, o-Ala2-Leu enkephalinamide, o-Ala2-Met-enkephalinamide (Serva), and naloxone (gift of Endo Labs, NY, U.S.A.). The sub stances were dissolved in an inert artificial CSF of the following composition (mM): Na+, 159.5; K+, 2.5; Ca2+, 1.5; Cl-, 150.5; HC0 3 -, 14.5. After equilibration with a mixture of 5% CO 2 and 95% N 2 (equilibrated with water), the solution had a pH of 7.25 (38°C) and an osmolarity of 308 mOsmol/L. The drugs in concentrations up to 10-4 (naloxone) and 10-3 (opioid agonists) M did not change the pH or osmolarity of the artificial CSF. Under our experimental conditions, the values of pH and K + of the artificial CSF are the same as those found in the natural CSF of the cortical subarachnoid space Wahl and Kuschinsky, 1979) . The osmolarity of the artificial CSF is very similar to that of the cisterna magna fluid (Wahl et aI., 1983) . Fresh solutions were pre pared daily in polystyrol vials and kept at O°C in a refrig erator. Glass capillaries used for microapplication and pi pettes were siliconized to prevent adsorption of the pep tides as reported previously (Wahl et aI., 1983) .
After penetration of the superficial layer of the arach noid membrane, glass capillaries with sharpened tips (8to 1O-[Lm outer diameter) were positioned in the perivas cular space of the vessel under investigation. Using a microperfusion pump, 5 [LI of the solution was applied within 40 s. Measurements of vascular diameter were made prior to the injection and at 20 and 40 s following application. The mean values of the latter two measure ments were used to calculate the change in vascular di ameter induced by the compounds tested. After mea suring the reactivity of each vessel to alteration in pH (Wahl et aI., 1970; Kuschinsky et aI., 1972) , the effect of the artificial CSF was tested. Subtraction of the indi vidual solvent effects revealed the data shown in the fig ures.
Statistical analysis
The statistical analyses was performed by analysis of variance and multiple comparisons, according to the method of Scheffe (1953) . In addition, we used a paired t test with the sequentially rejective Bonferroni procedure to ensure the mUltiple level of significance, according to the method of Holm (1979) . The 99% level was taken as significant.
RESULTS
Pial arteries with a resting diameter of 66.5-294 /-Lm (169 ± 6. 7 /-Lm, mean ± SEM) located in the parietal lobe were investigated. Perivascular appli cation of artificial CSF did not significantly change the diameter of the arteries (dilatation of 0. 68 ± 0. 25%). vascular response was not found for any of the four groups. Figure 3 shows the average concentration-re sponse curve obtained for the opioid receptor an tagonist naloxone. Naloxone did not change arterial diameter significantly when concentrations of 10 -5 or 10-4 M were applied perivascularly. However, a dilatation of 15. 3 ± 1. 6% was observed at 10-3 M naloxone. Statistical analysis revealed that the ef fect induced by 10-3 M naloxone was significantly different (p < 0.01) from the effect of the solvent alone as well as from the effects elicited by 10-4 and 10-5 M naloxone.
To evaluate whether the dilatations induced by high concentrations of the most effective agonist, o-Ala 2 -Leu-enkephalinamide, were mediated by specific opioid receptors, the antagonist naloxone was applied. The results are depicted in Fig. 4 . The compounds were injected into the perivascular space of the same artery in the following sequence:
first, 10-4 and 10-3 M o-Ala 2 -Leu-enkephalin amide, which dilated the vessels by 6. 4 and 14.3%, respectively (Fig. 4, left) ; then, 10-4 M naloxone, which dilated the vessels insignificantly; and finally, M. WAHL
DISCUSSION
The present results demonstrate that enkephalins acting from the perivascular side do not change the resistance of feline extraparenchymal arterioles and arteries in situ under physiological conditions. This is concluded from the finding that agonist concen trations of 10-11_ 10 -5 M were ineffecti ve. From de termination of opiate-like activity in samples of human CSF, one can estimate a total activity of 10-9_10-8 M, whereas the concentrations of Leu enkephalin and Met-enkephalin appear to be in the range of 10-11_10-10 M (Terenius and Wahlstrom, 1978; Nyberg and Te renius, 1982; Nyberg et aI. , 1983) . Although these concentrations will be in creased in the immediate vicinity of enkephalinergic synapses, it is very unlikely that they are> 10-6 M. If these values can be transferred to the cat, it is evident that in the surroundings of cerebral ves sels, vasoactive concentrations of endogenous Leu enkephalin and Met-enkephalin cannot be ex pected, which indicates that these enkephalins are probably not important for the regulation of pial ar terial resistance.
The dilatations measured at 10-4 and 10-3 M D Ala 2 -Leu-enkephalinamide and 10-3 M D-Ala2-Met enkephalinamide, Leu-enkephalin, and morphine are mediated by specific opioid receptors. Several subtypes of opioid receptors have been classified with regard to the binding and potency of various agonists and to the efficacy of the antagonist nal oxone to block these effects (Lord et aI. , 1976; Snyder and Childers, 1979; Wiister et aI. , Adler, 1981; Martin, 1981) . These receptors are named (agonist in brackets) /-1-(morphine), 0-(en kephalins), E-(j3-endorphin), K-(ketocylazocine), and (T-(N-allylnorcyclazocine) receptors. Consid ering that naloxone has the highest affinity to 1-1and o-receptors and D-Ala 2 -Leu-enkephalinamide, the most potent agonist of the present study, acts via both /-1-and o-receptors (Snyder and Goodman, 1980) , it can be concluded that the dilatations of pial arteries elicited by the four agonists used in the present study were mediated by these two receptor subtypes. It is very probable that these /-1-and 0receptors are located on vascular smooth muscles since the resting tone of feline pial arteries is not influenced by noradrenergic (Kuschinsky and Wahl, 1975) , cholinergic (Kuschinsky et ai. , 1974) , or substance P-containing (Edvinsson et ai. , 1982) nerves under our experimental conditions. There fore, a prejunctional effect of the agonists on opioid receptors located on vascular nerve endings is un likely as an explanation of the present results. How ever, such a mechanism cannot be excluded if vas cular nerves other than those mentioned above were involved in the regulation of pial arterial resting tone. The presence of /-1-opioid receptors on the muscle cells of the feline middle cerebral artery is supported by the findings of Harder and Madden (1984) . In their study, morphine 00-7-10-4 M) in duced an increase of the potassium conductance and hyperpolarization of smooth muscle cells, which was accompanied by a moderate dose-de-pendent relaxation if the isolated arteries were pre contracted.
At first glance, the present results are not in com plete accordance with the findings of Hanko and Hardebo (1978) . They found that low concentra tions of enkephalin (10-9-10-7 M) and morphine 00-8-10-6 M) produced dose-dependent relaxation of precontracted isolated feline cerebral arteries.
These effects could be blocked by naloxone. How ever, these authors (J. E. Hardebo, personal com munication) found later that they had overestimated the relaxing effect of the opioid agonists previously because of methodological reasons. In contrast to the results obtained with feline cerebral arteries, no evidence for fL-and o-opioid receptors could be found in canine cerebral arteries (Altura et al., 1983 (Altura et al., , 1984 . However, in these studies (1"-and K-opioid receptors were found to mediate contraction and relaxation of the isolated basilar and middle cere bral arteries elicited by high doses 00-5-10-3 M) of the corresponding agonists. This discrepancy ap pears to be due to species differences.
The present findings show that pure naloxone in concentrations of < 10 -4 M did not induce a vaso motor response per se of feline pial arteries when acting from the perivascular side. This indicates that the pial arterial resting diameter is not influ enced by an enkephalinergic component. Compa rable results have been obtained in the monkey after intravascular administration of naloxone (Boisvert, 1983 ). In addition, naloxone was without effect in precontracted (prostaglandin F2a, KCl) ring seg ments of human pial arteries (Brandt et aI., 1983) .
However, the contraction of strips of canine basilar artery that was induced by norepinephrine was re duced by naloxone (Sasaki et aI., 1984) . This might be explained by species differences. The dilatation of feline pial arteries in situ induced by 10 -3 M na laxone (Fig. 3) may be due to partial agonist and/or unspecific actions of naloxone. Since pure-sub stance naloxone was used, effects due to solvent or preservatives as shown for Nalonee by Brandt et al. (1983) can be excluded here. Although naloxone appears to be the most specific of the available opioid receptor antagonists, higher doses of nal oxone are known to produce similar effects to those of morphine (Sawynok et aI., 1979) . Such a partial agonist action is still more distinct for the antago nists naltrexone and nalorphine. Unspecific effects, or antagonism to nonopiate drugs, have also been reported for higher doses (3 x 10-4_10-3 M) of naloxone, which appear to have properties like a Ca 2 +-entry blocker (Sawynok et aI., 1979) . An ex ample of unspecific effects of naloxone in canine basilar artery in vitro has been reported by Sasaki et al. (1984) . These authors demonstrated that nal oxone (3 x 10-4 M) reduced the constriction in duced by norepinephrine, serotonin, hemoglobin, and KC1.
Considering the above-mentioned reports, it is obvious that naloxone (except at extremely high concentrations) exerts predominantly no direct vas cular effect. From this and from the lack of an effect on cerebral metabolism, which can be derived from an unchanged glucose uptake (Artru et aI., 1980; Dunn and Hurd, 1982; Shigeno et aI., 1983) , one may expect that naloxone does not alter CBF. In deed, this has been found in dog (Artru et aI., 1980) , rabbit (Koskinen and Bill, 1983) , and cat (Levy et aI., 1982) under normal conditions. In ischemic re gions of cat and dog brain, a decrease (Levy et aI., 1982) and increase (Faden et aI., 1982) of CBF have been detected, respectively. The less specific opioid receptor antagonists naltrexone and nalorphine re duced CBF and CMR02 in cat (Grandison et aI., 1982) and dog (Takeshita et aI., 1972) . This latter finding can be explained by the partial opiate ago nist action of both compounds.
A partial reversal of ischemic neurologic deficits and an improvement of neurophysiological param eters such as evoked potentials after treatment with naloxone have been detected in humans and several animal models (Faden et aI., 1982; Levy et aI., 1982; Sugar, 1983; Zabramski et aI., 1984) . Regarding the present results, one may suggest that the beneficial effects of naloxone after ischemic events are not due to a primary action on cerebral vasculature and CBF. It is more probable that naloxone modulates primarily synaptic transmission and neuronal func tion, which may then induce secondary changes of cerebral metabolism and blood flow.
